These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 714258)

  • 21. [The quantitative determination of HBSAG--a valuable aid in evaluating the infectiousness of hepatitis B virus carriers].
    Löschner J; Fengler JD; Baumgarten R
    Z Arztl Fortbild (Jena); 1981 Nov; 75(22):1084-5. PubMed ID: 7340196
    [No Abstract]   [Full Text] [Related]  

  • 22. Difference of subtypes of hepatitis B surface antigen between asymptomatic carriers and patients with chronic liver diseases.
    Nakamura S; Takezawa Y; Maeda T
    Tohoku J Exp Med; 1980 Nov; 132(3):367-8. PubMed ID: 6162245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Markers of infectivity in carriers of the hepatitis B surface antigen].
    Sekerová Z; Olesová B; Kutálek E
    Cesk Epidemiol Mikrobiol Imunol; 1990 Jun; 39(3):171-7. PubMed ID: 2144478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [HBeAg and anti-HBe levels in HBsAg positive blood donors].
    Hasçelik G; Günalp A
    Mikrobiyol Bul; 1989 Jan; 23(1):23-9. PubMed ID: 2626096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [HBsAg carrier state and primary hepatocellular carcinoma--a ten-year prospective study].
    Lu JH
    Zhonghua Yu Fang Yi Xue Za Zhi; 1988 Sep; 22(5):259-62. PubMed ID: 2853039
    [No Abstract]   [Full Text] [Related]  

  • 26. Tissue markers of hepatitis B virus infection in hepatocellular carcinoma and cirrhosis.
    Craxi A; Pasqua P; Giannuoli G; Di Stefano R; Simonetti RG; Pagliaro L
    Hepatogastroenterology; 1984 Apr; 31(2):55-9. PubMed ID: 6327478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating immune complexes in chronic hepatitis as related to the presence of HBsAg.
    Radu D; Dumitraşcu D; Părău N; Urcan S; Stanciu L; Tăpălagă D; Ban A; Dumitraşcu D; Rusu C
    Med Interne; 1984; 22(1):61-5. PubMed ID: 6710050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serological profiles of hepatitis B carrier patients in Singapore with special reference to the frequency and significance of concurrent presence of HBsAg and anti-HBs.
    Wang YM; Ng WC; Kang JY; Yap I; Seet BL; Teo J; Smith R; Guan R
    Singapore Med J; 1996 Apr; 37(2):150-2. PubMed ID: 8942251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship of hepatitis B e antigen, DNA polymerase activity, and titer of hepatitis B surface antigen with ongoing liver injury in chronic hepatitis B virus infection.
    Perrillo R; Campbell C; Wellinghoff W; Gelb L
    Am J Gastroenterol; 1982 Jul; 77(7):445-9. PubMed ID: 7091131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of alcohol on the liver in HBsAg carriers.
    Itoh S; Shimoji K
    Am J Gastroenterol; 1986 Sep; 81(9):779-82. PubMed ID: 3752040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA system and its association to chronic hepatitis and persistence of HBsAg in the organism.
    Horejsi J; Cerhova M; Majsky A; Mimra J
    Tijdschr Gastroenterol; 1978; 21(6):457-64. PubMed ID: 756103
    [No Abstract]   [Full Text] [Related]  

  • 32. Hepatocellular carcinoma in young, mentally retarded HBsAg carriers without cirrhosis.
    Lohiya G; Pirkle H; Hoefs J; Lohiya S; Ngo VT
    Hepatology; 1985; 5(5):824-6. PubMed ID: 2993146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [106 cases of HBsAg carriers and factors influencing the prognosis: a follow-up study of 7-12 years].
    Hong DQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 1985 Aug; 6(4):223-6. PubMed ID: 4092225
    [No Abstract]   [Full Text] [Related]  

  • 34. Assessment of alpha-fetoprotein in chronic HBsAg carriers and in HBsAg negative cirrhosis of the liver.
    Stránský J; Zichová M; Vodák M
    Sb Lek; 1993; 94(4):311-5. PubMed ID: 7527585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [An HBsAg carrier who became carrier through exchange transfusion and developed liver cirrhosis despite the disappearance of HBsAg].
    Ishihara K; Hayashi J; Kajiyama W; Ishibashi H; Kashiwagi S
    Kansenshogaku Zasshi; 1988 Jun; 62(6):608-12. PubMed ID: 3138332
    [No Abstract]   [Full Text] [Related]  

  • 36. [Immunological aspects of primary carcinoma of the liver].
    Amuso M; Cottone M; D'Amico G; Di Piazza S; Filippazzo G; Le Moli S; Maniscalco EG; Oliva L; Pagliaro L; Palazzo U; Pasta L; Pinzello G; Rinaldi F; Dardanoni L; Gulì V; La Rosa G; Genova G
    Minerva Med; 1978 Aug; 69(38):2581-6. PubMed ID: 82235
    [No Abstract]   [Full Text] [Related]  

  • 37. [Frequency and clinical relevance of delta virus infection in HBsAg carriers in the Berlin area].
    Möller B; Hopf U; Hoffmann H; Alexander M; Lobeck H
    Z Gastroenterol; 1988 Jun; 26(6):314-21. PubMed ID: 3264646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Distribution of the antigen of hepatitis B virus in liver tissue in healthy carriers and in patients with chronic active and acute hepatitis].
    Garciá-Ruiz H; Sotto-Escobar A; Gra-Oramas B
    Rev Gastroenterol Mex; 1989; 54(2):87-90. PubMed ID: 2772481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Long-term observation of HBsAg positive patients and carriers (author's transl)].
    Wu BP
    Zhonghua Yu Fang Yi Xue Za Zhi; 1981 Jul; 15(4):245-7. PubMed ID: 7333195
    [No Abstract]   [Full Text] [Related]  

  • 40. [Importance of the immune system in the symptom-free HBsAg carrier state].
    Mansurov KhKh; Asfandiiarova NS
    Klin Med (Mosk); 1984 Jun; 62(6):17-21. PubMed ID: 6381874
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.